XENON PHARMACEUTICALS INC. (XENE) Free cash flow 2016–2025
XENON PHARMACEUTICALS INC. (XENE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$279.9MFY2025 · since FY2016: -$19.8M → -$279.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$279.9M | -51.7% |
| FY2024 | -$184.5M | -17.7% |
| FY2023 | -$156.7M | -50.8% |
| FY2022 | -$103.9M | -45.2% |
| FY2021 | -$71.6M | -41.0% |
| FY2020 | -$50.8M | -752.6% |
| FY2019 | -$6.0M | +83.1% |
| FY2018 | -$35.2M | -21.3% |
| FY2017 | -$29.0M | -46.3% |
| FY2016 | -$19.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More XENE financial trends
XENE RevenueXENE Net incomeXENE Net marginXENE Gross profitXENE Gross marginXENE Operating incomeXENE Operating marginXENE Operating cash flowXENE Capital expendituresXENE Return on equityXENE Stock buybacksXENE Dividends paidXENE Total assetsXENE Total liabilitiesXENE Shareholders’ equityXENE overview →